Pfizer : PFE

All Pfizer Articles

1482 Articles

Trey Thoelcke | Apr 11, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the March 15 and March 29…

Chris Lange | Apr 2, 2018 at 1:20 PM EDT

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Mar 27, 2018 at 6:15 AM EDT

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the February 28 and March 15…

Paul Ausick | Mar 23, 2018 at 4:01 PM EDT

DowDuPont, 3M Sink the Dow Friday

DowDuPont, Goldman Sachs, 3M Company, and Pfizer pushed the Dow lower again Friday.

Chris Lange | Mar 23, 2018 at 10:25 AM EDT

Pfizer’s Chantix Study Goes Up in Smoke

Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 12, 2018 at 7:00 AM EDT

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

As of the most recently reported period, short sellers still favored just two Dow stocks, General Electric and Intel, above…

Paul Ausick | Mar 8, 2018 at 4:07 PM EST

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

The Dow wobbled around Thursday and looks set to close very near the break-even line as J&J, Pfizer, Caterpillar, and…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Feb 22, 2018 at 2:52 PM EST

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

If the collaboration between Sangamo and Kite Pharma works out, some investors might just ask why Gilead did not just acquire Sangamo.

Paul Ausick | Feb 16, 2018 at 4:01 PM EST

Pfizer, UnitedHealth Boost DJIA on Friday

Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Jon C. Ogg | Jan 31, 2018 at 1:55 PM EST

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

These are the 10 stocks tracked by 24/7 Wall St. that received multiple analyst rating upgrades or price target hikes…

1 … 35 36 37 38 39 … 99

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted NYSE Stocks

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Which Major Pharma Stocks Short Sellers Are Keen On

The 6 Most Shorted NYSE Stocks

DowDuPont, 3M Sink the Dow Friday

Pfizer’s Chantix Study Goes Up in Smoke

Major Pharma Sees Big Drop in Short Interest

GE and Intel Remain Short Sellers’ Favorite Dow Stocks

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

Short Sellers Hike Bets in Major Pharma

Should Gilead Just Have Tried to Acquire Sangamo Rather Than a Collaboration Pact?

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later